Results Announcements News Details
Pfizer standalone net profit declines 39.62% in the March 2026 quarter
(13-May-26 07:28)
Net profit of Pfizer declined 39.62% to Rs 199.82 crore in the quarter ended March 2026 as against Rs 330.94 crore during the previous quarter ended March 2025. Sales rose 6.31% to Rs 629.23 crore in the quarter ended March 2026 as against Rs 591.91 crore during the previous quarter ended March 2025.
For the full year,net profit declined 5.88% to Rs 722.43 crore in the year ended March 2026 as against Rs 767.60 crore during the previous year ended March 2025. Sales rose 10.45% to Rs 2519.65 crore in the year ended March 2026 as against Rs 2281.35 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 629.23 | 591.91 | 6 | 2519.65 | 2281.35 | 10 |
| OPM % | 37.50 | 38.43 | - | 35.88 | 32.45 | - |
| PBDT | 274.56 | 269.39 | 2 | 1082.56 | 904.07 | 20 |
| PBT | 259.78 | 252.99 | 3 | 1024.83 | 843.28 | 22 |
| NP | 199.82 | 330.94 | -40 | 722.43 | 767.60 | -6 |
Powered by Capital Market - Live News
